Evidence map›Paper›PMID 41562193›Full record

ArticleGenes, chromosomes & cancer2026

Endogenous Processes Underlying Clock-Like Mutational Signatures.

Teresa Druck, Rami I Aqeilan, C Marcelo Aldaz, Nicola Zanesi, Kay Huebner

Abstract read
In one paragraph

Article in Genes, chromosomes & cancer, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Teresa DruckDepartment of Cancer Biology and Genetics, Ohio State University Comprehensive Cancer Center, Columbus, Ohio, USA.ORCID 0000-0002-1382-9868
Rami I AqeilanDepartment of Cancer Biology and Genetics, Ohio State University Comprehensive Cancer Center, Columbus, Ohio, USA.
C Marcelo AldazDepartment of Epigenetics and Molecular Carcinogenesis, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Nicola ZanesiDepartment of Cancer Biology and Genetics, Ohio State University Comprehensive Cancer Center, Columbus, Ohio, USA.
Kay HuebnerDepartment of Cancer Biology and Genetics, Ohio State University Comprehensive Cancer Center, Columbus, Ohio, USA.

Funding

Translational Therapeutics Research Program (TT)P30CA016058 · NCI · OHIO STATE UNIVERSITY · PI Daniel G. Stover · 1985 to 2026
$132.3M
NCI NIH HHS P30 CA016058NCI NIH HHS P30CA016058
6 · The paper itself

Abstract

Wellcome Trust scientists have shown that "mutational signatures" in specific nucleotide contexts accumulate in genomes of mammalian tissues, providing clues to underlying causes of specific signatures. Analysis of cancer genomes has identified more than 50 single-base substitution (SBS) signatures, with SBS1, SBS5, and SBS40 linked to aging and present in normal tissues. SBS1 results from cytosine demethylation, whereas SBS5 and SBS40 arise from unknown endogenous mechanisms. We hypothesized that loss of fragile-site genes drives these two signatures. FHIT, located at FRA3B, is frequently deleted in cancers, and Fhit-deficient mouse tissues exhibit a mutation profile resembling human SBS5. Data mining of cancer genome sequences showed that FHIT/Fra3B was the gene loss most significantly correlated with human SBS5 mutations, likely representing the endogenous molecular process determining SBS5 mutations in soma, germ cells, and cancers, and inversely associated with lifespan in mammals. Exome sequences of Fhit knockout tissues revealed ~1000 SBS1 and ~4000 SBS5 mutations per sample, compared to markedly fewer in wild-type controls. Using SigProfilerAssignment, similar analyses performed with Fhit ko samples where Wwox is also frequently lost identified SBS40c. These findings implicate fragile-site gene inactivation as a major source of clock-like mutational signatures, contributing to lifelong mutation accumulation and potentially influencing aging, evolution, and speciation.

Indexed as

Acid Anhydride HydrolasesMutationNeoplasm ProteinsNeoplasmsAgingAnimalsBis(5'-adenosyl)triphosphataseChromosome Fragile SitesHumansMiceMice, KnockoutAcid Anhydride HydrolasesBis(5'-adenosyl)triphosphataseNeoplasm Proteinsagingcancer signaturesFhitfragile sitesgermlinemutational signaturesWwox

Identifiers

PMID41562193
PMCPMC12820907

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.